Laird Norton Wetherby Wealth Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$237K	Buy	1,517 +6	+0.4%	+$953	0.01%	825
2025 Q2	$229K	Buy	+1,511	New	+$201K	0.01%	819
2024 Q4	$296K	Sell	1,603 -68	-4%	-$13.1K	0.01%	704
2024 Q3	$329K	Sell	1,671 -36	-2%	-$7.48K	0.02%	698
2024 Q2	$353K	Hold	1,707	–	–	0.02%	652
2024 Q1	$463K	Sell	1,707 -73	-4%	-$17.4K	0.02%	584
2023 Q4	$421K	Buy	1,780 +10	+0.6%	+$1.97K	0.02%	604
2023 Q3	$347K	Sell	1,770 -139	-7%	-$28.5K	0.02%	635
2023 Q2	$401K	Buy	1,909 +8	+0.4%	+$1.59K	0.02%	616
2023 Q1	$384K	Sell	1,901 -26	-1%	-$5.89K	0.02%	625
2022 Q4	$420K	Buy	1,927 +23	+1%	+$5.02K	0.03%	575
2022 Q3	$375K	Sell	1,904 -46	-2%	-$9.93K	0.03%	581
2022 Q2	$417K	Buy	1,950 +157	+9%	+$38.4K	0.03%	555
2022 Q1	$509K	Buy	1,793 +44	+3%	+$13.6K	0.03%	515
2021 Q4	$659K	Sell	1,749 -188	-10%	-$73K	0.04%	423
2021 Q3	$799K	Sell	1,937 -13	-0.7%	-$5.4K	0.05%	357
2021 Q2	$721K	Buy	+1,950	New	+$651K	0.04%	387
2021 Q1	–	Sell	-1,935	Closed	-$483K	–	802
2020 Q4	$483K	Buy	+1,935	New	+$461K	0.03%	473